@dansfera: Mind-blowing take on Big Pharma's pipeline! 🤯 If over 75% of candidates fail *after* Phase 2 testing, does that intense bottleneck of Phase 3 trials even make sense anymore? This perspective challenges the system, proposing that if a drug is proven safe in early phases, its long-term efficacy could potentially be determined through monitored, open market use instead. Revolutionary idea or a regulatory nightmare waiting to happen? 🤔 Let the debate ignite! #DrugTrials #MedTech #Pharma #ScienceDebate #HealthcareInnovation